Home
Discover
Research
Finance
Strategy

Get 40% off Premium. Unlock the BEST of AlphaPilot.

Finance
TOVX

Overview Financials Analysis Smart Money

Theriva Biologics, Inc.

TOVX · AMEX

Analyze with AI

Filings1

Total reported value$0.0

Manager	Shares	Value	Change
Planning Capital Management Corp	0	$0.0	+100.0%

SymbolTOVX

Market Cap$6.2M

IPO Date2006-12-18

CEOSteven A. Shallcross

Employees20

SectorHealthcare

IndustryBiotechnology

CountryUS

ExchangeNew York Stock Exchange Arca

Luminar Technologies, Inc.

LAZR

$0.6044

+174.73%

NovaBay Pharmaceuticals, Inc.

NBY

$5.30

+79.66%

Mint Incorporation Limited

MIMI

$0.4795

+75.45%

Autozi Internet Technology (Global) Ltd.

AZI

$2.50

+64.47%

GD Culture Group Limited

GDC

$5.26

+51.59%

Peers

Galmed Pharmaceuticals Ltd.

GLMD · NASDAQ

$0.8512

-4.24%

BioVie Inc.

BIVI · NASDAQ

$1.41

-2.76%

NKGen Biotech, Inc. Common Stock

NKGN · NASDAQ

$0.051

+37.84%

PMGC Holdings Inc.

ELAB · NASDAQ

$2.26

+3.67%

Moolec Science S.A.

MLEC · NASDAQ

$0.3261

-2.37%

iSpecimen Inc.

ISPC · NASDAQ

$0.37

-4.59%

Windtree Therapeutics, Inc.

WINT · NASDAQ

$0.0375

-6.25%

BriaCell Therapeutics Corp. Warrant

BCTXZ · NASDAQ

$0.39

+0.00%

Chemomab Therapeutics Ltd.

CMMB · NASDAQ

$1.89

-1.56%

Carisma Therapeutics, Inc.

CARM · NASDAQ

$0.0446

-8.61%

Home

Home
Research
Strategy
Signal
Discover

Education

Academy
Tutorial
Strategy
Agent
Finance

Resources

Pricing
Referral
Partners
FAQ

Other

Terms
Privacy

Disclaimer: Content on AlphaPilot is for informational purposes only and does not constitute financial or investment advice. Past performance, including backtested results, is not indicative of future outcomes. AlphaPilot makes no guarantees regarding accuracy or reliability; use at your own risk.